Avadel Pharmaceuticals Plc (NASDAQ: AVDL) Starts Presentation at 29th Annual ROTH Conference
Avadel Pharmaceuticals (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to develop. The company utilizes its proprietary drug delivery technology and in-licensing or acquiring new products to ultimately help patients see better results. Avadel currently markets products in the hospital and primary care spaces. The company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. For more information, visit the company’s website at www.avadel.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social…







